Aarti Pharmalabs Ltd Quarterly Result
Aarti Pharmalabs Ltd
NSE: AARTIPHARMA
Net Profit - Last Quarter
Aarti Pharmalabs Ltd Quarterly Results Key Highlights
- The revenue of Aarti Pharmalabs Ltd for the Dec '25 is ₹ 436.83 crore as compare to the Sep '25 revenue of ₹ 418.39 crore.
- This represent the growth of 4.41% The ebitda of Aarti Pharmalabs Ltd for the Dec '25 is ₹ 104.07 crore as compare to the Sep '25 ebitda of ₹ 74.13 crore.
- This represent the growth of 40.39% The net profit of Aarti Pharmalabs Ltd for the Dec '25 is ₹ 47.96 crore as compare to the Sep '25 net profit of ₹ 27.92 crore.
- This represent the growth of 71.78%.
Aarti Pharmalabs Ltd Quarterly Results Analysis
Market Price of Aarti Pharmalabs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 18 May 2026 | 701.05 |
| 15 May 2026 | 714.8 |
| 14 May 2026 | 718.7 |
| 13 May 2026 | 706.25 |
| 12 May 2026 | 711.7 |
| 11 May 2026 | 743.55 |
| 08 May 2026 | 766.8 |
| 07 May 2026 | 776.6 |
| 06 May 2026 | 788.5 |
| 05 May 2026 | 771.9 |
Historical Revenue of Aarti Pharmalabs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Aarti Pharmalabs Ltd
Historical EBITDA of Aarti Pharmalabs Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Aarti Pharmalabs Ltd
Historical Net Profit of Aarti Pharmalabs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aarti Pharmalabs Ltd
Aarti Pharmalabs Ltd News Hub
Aarti Pharmalabs consolidated net profit rises 17.75% in the June 2024 quarter
Net profit of Aarti Pharmalabs rose 17.75% to Rs 55.45 crore in the quarter ended June 2024 as again
Read more
05 Aug 24
Aarti Pharmalabs to discuss results
Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 October 2024. Po
Read more
22 Oct 24
Aarti Pharmalabs consolidated net profit rises 5.44% in the September 2024 quarter
Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September 2024 as a
Read more
28 Oct 24
Aarti Pharmalabs Company Secretary resigns
Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the position o
Read more
28 Oct 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Aarti Pharmalabs Ltd
- Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019.
- The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022.
- Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India.
- It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
FAQs for Quarterly Results of Aarti Pharmalabs Ltd
What key financial metrics are included in Aarti Pharmalabs Ltd's quarterly results?
When does Aarti Pharmalabs Ltd announce its quarterly results?
How does Aarti Pharmalabs Ltd's quarterly performance impact its stock price?
What is the impact of Aarti Pharmalabs Ltd's quarterly results on dividends?
Are there any special announcements usually made during Aarti Pharmalabs Ltd's quarterly results?
